INTRODUCTION
============

Liver cancer is the second most common cancer among other cancers and is the leading cause of cancer deaths \[[@b1-jcp-24-072]\]. Hepatocellular carcinoma (HCC), which occurs approximately in 90% of primary liver cancer, causes serious health problems worldwide \[[@b2-jcp-24-072]\]. Liver cirrhosis is the main cause of HCC and almost one third of patients develop HCC. Hepatitis C virus and hepatitis B virus are also associated with HCC with cofactors, such as alcohol consumption, smoking and aflatoxin \[[@b3-jcp-24-072]\]. Hepatic steatosis is often accompanied by hepatocyte injury and inflammation leading to cirrhosis and HCC \[[@b4-jcp-24-072]\]. The main reason for the high mortality rate of HCC patients is the lack of effective treatment and the asymptomatic nature of early HCC \[[@b5-jcp-24-072],[@b6-jcp-24-072]\].

Amino acids are organic substances containing amine and carboxylic acid functional groups \[[@b7-jcp-24-072]\], which are the basic unit for protein synthesis in cellular metabolism. Also, amino acids serve as intermediate metabolites affecting the biosynthesis of lipids, glutathione, nucleotides, glucosamine, and polyamines as well as cell proliferation and tricarboxylic acid circulating carbon \[[@b8-jcp-24-072],[@b9-jcp-24-072]\]. Liver is an important organ for protein synthesis, degradation and detoxification as well as amino acid metabolism \[[@b10-jcp-24-072]\]. In the liver, abundant non-essential amino acids such as alanine, aspartate, glutamate, glycine, and serine and essential amino acids, such as histidine and threonine are present \[[@b9-jcp-24-072]\]. Recent studies have reported the role of amino acids as promising agents in the management of proliferative metabolism, and the application of amino acids has been rapidly increased in a variety of therapeutic fields \[[@b8-jcp-24-072]\]. Therefore, we described the biochemical properties and therapeutic functions of each amino acid for liver diseases in this review.

FUNCTIONS OF AMINO ACIDS IN LIVER DISEASES
==========================================

1. Alanine
----------

Alanine plays an important role in transferring ammonia from the periphery to the liver. Glucose is absorbed into the muscle and degraded by glycolysis to produce pyruvate then accepts amino group to form alanine. Produced alanine is released and uptaken into the liver and regenerates glucose and urea \[[@b11-jcp-24-072]\]. Alanine negatively regulates pyruvate kinase and participates in gluconeogenesis to help the production of glucose by hepatocytes in food shortages \[[@b12-jcp-24-072]\]. The alanine-pyruvate interconversion is caused by the alanine transaminase (ALT) enzyme expressed in the liver \[[@b13-jcp-24-072]\]. ALT is an enzyme that forms oxaloacetate, a liver metabolite \[[@b14-jcp-24-072]\]. ALT is abundant in the cytoplasm of hepatocytes and its activity in the liver is about 3,000 times higher than in serum. Therefore, when hepatocytes are damaged, ALT is released into the serum from injured hepatocytes, increasing the serum ALT activity \[[@b15-jcp-24-072]\]. Alanine treatment has been reported to significantly decrease the plasma levels of ALT and total bilirubin in Spragur-Dawley (SD) rat treated with D-galactosamine (D-gal) \[[@b16-jcp-24-072]\]. Alanine administration has been reported to prevent the elevation of ALT and histological liver damage in CCl~4~-induced hepatocyte necrosis rat model \[[@b17-jcp-24-072]\]. In addition, the treatment with alanine significantly decreased the level of lactate dehydrogenase in D-gal-treated rat hepatocytes \[[@b17-jcp-24-072]\]. In high-fat diet-induced obesity model, intake of alanine not only reduced body fat mass, but also decreased epididymal white adipose tissue. Moreover, the expressions of lipogenic genes such as fatty acid synthase (FAS) and liver-type fatty acid binding protein were significantly reduced by alanine treatment \[[@b18-jcp-24-072]\].

2. Glutamate
------------

Glutamate inhibits T-cell and inflammatory responses and maintains the hepatic urea cycle in an active state for the detoxification of ammonia \[[@b7-jcp-24-072],[@b12-jcp-24-072]\]. Glutamate modulates the transport of reductase across the membrane of mitochondria, thereby affecting glycolysis and cellular redox status \[[@b19-jcp-24-072]\]. Also, it acts as a major antioxidant in cells by controlling the homeostasis of free radicals \[[@b20-jcp-24-072]\]. Moreover, glutamate plays an important role in amino acid metabolism because it makes enzymes that metabolize and synthesize various amino acids in the liver \[[@b21-jcp-24-072]\]. In the rabbits treated with oxidized mustard oil, the intake of glutamate not only increased the level of glucose but also significantly decreased total levels of cholesterol and triglyceride in serum \[[@b22-jcp-24-072]\]. The oxidized mustard oil treatment significantly alters liver structure, increases fat accumulation, causes hepatitis, and necrosis. The co-administration of glutamate however, restored the function and structure of the liver \[[@b22-jcp-24-072]\]. In addition, it has been reported that the administration of alpha-ketoglutarate (AKG), a precursor of glutamate, reduced the activity of aspartate aminotransferase and ALT and improved the structure and physiological activity of the liver in lipopolysaccharide (LPS)-induced liver injury animal model \[[@b23-jcp-24-072]\].

3. Aspartate
------------

Aspartate is an acidic amino acid considered as a non-essential amino acid \[[@b7-jcp-24-072]\]. However, many studies have shown that aspartate plays an important role in the physiological process of the liver \[[@b24-jcp-24-072],[@b25-jcp-24-072]\]. Aspartate is required for the synthesis of purine, pyrimidine, asparagine, and arginine and is involved in the synthesis of inositol and beta-alanine \[[@b7-jcp-24-072]\]. It can be synthesized from oxaloacetate, which plays an important role in the citric acid cycle and affects cellular redox status \[[@b19-jcp-24-072]\]. Supplementation of aspartate has been reported to suppress atherosclerosis and fatty liver disease in cholesterol-fed rabbits \[[@b26-jcp-24-072]\]. It has been reported that intake of aspartate can inhibit the development of hepatic steatosis and liver fibrosis \[[@b26-jcp-24-072]\]. The treatment with aspartate has also shown to have beneficial effects in attenuating liver damage through down-regulation of the expression of pro-inflammatory mediators, such as toll-like receptor 4 and nucleotide-binding oligomerization domain protein signaling genes in LPS-induced liver injury models \[[@b27-jcp-24-072]\].

4. Glycine
----------

Glycine is essential raw material for the synthesis of DNAs and RNAs. It can also improve the immune response and also involved in the absorption of calcium \[[@b28-jcp-24-072]\]. Glycine has been reported to protect against hypoxia in kidney proximal tubules and hepatocyte \[[@b29-jcp-24-072],[@b30-jcp-24-072]\]. In addition, glycine activates chloride channels in Kupffer cells and hyperpolarizes the membrane of cells. It increases intracellular calcium ion concentration and also reduces the levels of superoxide ions via glycine gated chloride channels \[[@b31-jcp-24-072]\]. In chronic rat hepatotoxicity models induced by CCl~4~, glycine treatment has been reported to prevent liver fibrosis by inhibiting the activation of Kupffer cells and preventing the release of pro-inflammatory and pro-fibrogenic cytokines \[[@b32-jcp-24-072]\]. Glycine has been also reported to increase the levels of myeloperoxidase and decrease the levels of TNF-α, thereby maintaining cell viability and organ regeneration capacity after liver transplantation in liver transplantation rat models \[[@b33-jcp-24-072]\]. Administration of glycine decreased oxidative stress and increased the expression of antioxidant enzymes, such as glutathione peroxidase, superoxide dismutase, and catalase in ethanol-induced liver injury model \[[@b34-jcp-24-072]\]. In addition, glycine administration not only increased the serum levels of vitamin E and C, but also relieved the infiltration of inflammatory cells in liver \[[@b34-jcp-24-072]\]. It has also been reported that ingestion of glycine improves survival rate and liver function by controlling the production of pro-inflammatory or anti-inflammatory cytokines in the endotoxin-induced liver injury mouse model \[[@b35-jcp-24-072]\]. Similarly, dietary supplementation of glycine has been shown to alleviate liver and lung injury and improve survival rate in SD rats injected with endotoxin intravenously \[[@b36-jcp-24-072]\]. In addition, dietary glycine accelerated the recovery of alcohol-induced liver damage over 4 weeks \[[@b37-jcp-24-072]\].

5. Histidine
------------

Histidine regulates gene expression and biological activity of proteins through methylation. It also regulates the structure and function of hemoglobin \[[@b7-jcp-24-072]\]. It has been reported that histidine ingestion reduces the accumulation of copper in the liver and promotes the excretion of copper into the urine in Wilson's disease which is caused by accumulation of copper \[[@b38-jcp-24-072]\]. The concentration of histidine, hepatic antioxidant enzyme activity, the levels of lipids and ALT were analyzed in long-evans cinnamon rats. As a result, the levels of cholesterol and ALT were reduced in rats under histidine diet \[[@b38-jcp-24-072]\]. Moreover, preliminary intake of histidine in a BALB/cA mouse model with hepatic injury induced by acetaminophen has been reported to reduce the levels of inflammatory cytokines, interleukin (IL)-6, IL-10, and TNF-α in the liver \[[@b39-jcp-24-072]\]. It has also been reported that the treatment with histidine alleviates hyperglycemia, hyperlipidemia, oxidation, and inflammation in diabetic mouse \[[@b39-jcp-24-072],[@b40-jcp-24-072]\]. Histidine has been reported to regulate hepatic glucose metabolism and activate hepatic STAT3 to act as an agent for the treatment of type 2 diabetes \[[@b41-jcp-24-072]\]. Histidine ingestion decreased lipogenesis and cholesterol metabolism related to mRNA expression, such as FAS, HMG-CoA reductase, regulatory element-binding protein-1c, and regulatory element-binding protein-2, which reduced body weight, epididymal fat and the levels of hepatic triglyceride and cholesterol \[[@b42-jcp-24-072]\]. It has also been reported that insulin sensitivity is improved and hyper-insulinemia is alleviated by the treatment with histidine \[[@b42-jcp-24-072]\].

6. Serine
---------

Serine is classified as a non-essential amino acid because serine can be produced from food consumption, degradation of proteins, glycine, saccharide metabolite and phospholipids \[[@b43-jcp-24-072],[@b44-jcp-24-072]\]. Serine, like glycine, provides precursors of proteins, nucleic acids, and lipids \[[@b45-jcp-24-072]\]. Moreover, serine which is involved in glycogen storage in liver and muscle, forms antibodies to enhance immunity, and helps the formation of the myelin sheath in nerve fibers \[[@b28-jcp-24-072]\]. Analysis of transcriptomic data of non-alcoholic steatohepatitis (NASH) patients in clinical trials confirmed the changes in several gene expressions by serine administration \[[@b43-jcp-24-072]\]. The hydroxymethyltransferases, cystein synthesis and aminoacyl-tRNA biosynthesis genes were decreased, whereas sphingosine synthesis genes were increased. It has been reported that the elevation of serine levels in hepatocytes via serine ingestion may have a beneficial effect on NASH patients through the regulation of these genes \[[@b43-jcp-24-072]\]. In alcohol-induced fatty liver mouse model, serine intake has been reported to reduce the hepatic level of triglyceride and neutral lipid accumulation \[[@b46-jcp-24-072]\]. It was also reported that serine increases the levels of glutathione and S-adenosylmethionine (SAMe), respectively \[[@b46-jcp-24-072]\].

7. Threonine
------------

Threonine is an essential amino acid and involved in many physiological and biochemical processes including growth, absorption, digestion and immune function \[[@b47-jcp-24-072]--[@b50-jcp-24-072]\]. In order to maintain intestinal function, threonine modulates the synthesis and immunity of the mucin proteins \[[@b51-jcp-24-072]\]. Also, threonine affects the synthesis of glycine and protein phosphorylation \[[@b7-jcp-24-072]\]. Threonine catabolism occurs mainly in the liver through two pathways \[[@b52-jcp-24-072]\], the enzymes threonine dehydratase (TDH) and threonine dehydrogenase (TDG). The enzyme, TDH, acts as a cytoplasmic enzyme to produce 2-ketobutyric acid and NH~4~^+^ \[[@b53-jcp-24-072],[@b54-jcp-24-072]\]. The enzyme TDG is a mitochondrial enzyme that produces glycine and aminoacetone \[[@b55-jcp-24-072]\]. In rat with hepatitis, the activity of TDH and TDG were markedly decreased. Therefore, the concentration of threonine in the liver was increased \[[@b56-jcp-24-072]\]. Dietary intake of threonine deficiency has been reported to reduce energy expenditure and promote mitochondrial uncoupling in the liver \[[@b57-jcp-24-072]\].

8. Others
---------

Methionine is an essential amino acid in humans. Methionine converts to SAMe and changes the methyl group of SAMe to S-adenosylhomocysteine \[[@b58-jcp-24-072]\]. The SAMe has isoenzymes, such as MAT1A and MAT2A. MAT1A is expressed primarily in the human liver and MAT2A is expressed in all organs including liver \[[@b59-jcp-24-072]\]. The patients with liver cirrhosis have abnormal methionine metabolism \[[@b60-jcp-24-072]\] and decreased MAT1A expression \[[@b61-jcp-24-072]\]. Indeed, several studies have shown that mice treated with methionine and choline deficient diets develop more severe steatohepatitis and HCC \[[@b62-jcp-24-072]\]. Leucine is an essential amino acid and is required for protein biosynthesis. Most leucine is metabolized in the liver, adipose tissue and muscle. Recent studies have shown that ingestion of leucine reverses abnormal metabolisms, improves glucose tolerance and decreases hepatic steatosis and inflammation in adipose tissue \[[@b63-jcp-24-072]\]. Arginine is necessary for cell division, removal of ammonia in the body and protein biosynthesis. Administration of arginine not only reduced endotoxin and lipid peroxidation induced by alcohol in liver injury rat model, but also reduced the level of inflammation factors, such as NF-κB, TNF-α, and COX2 \[[@b64-jcp-24-072]\].

CONCLUSION
==========

Liver cancer mortality is still high in the world because of its asymptomatic, difficulty in diagnosis and lack of effective treatment. Failure to treat the liver damaged by external factors can lead to more severe conditions such as fibrosis, cirrhosis and liver cancer ([Fig. 1](#f1-jcp-24-072){ref-type="fig"}) \[[@b65-jcp-24-072]\]. The liver is known to be involved in metabolic homeostasis, especially in glucose homeostasis through the alanine-glucose cycle \[[@b66-jcp-24-072]\]. The alanine-glucose cycle is a mutual reaction between the muscle and the liver. When the muscle protein breaks down the amino acids due to energy needs, released nitrogen participates in conversion of glutamate and pyruvate to AKG and alanine through transamination. The produced alanine is a metabolic pathway to the liver where pyruvate is used to make glucose \[[@b67-jcp-24-072],[@b68-jcp-24-072]\]. Amino acids have been found to be involved in a variety of biological activities, and the proper treatment with amino acids in liver disease can have positive effects summarized in [Table 1](#t1-jcp-24-072){ref-type="table"}. Recent studies reported the application of multiple amino acids such as peptides and branched chain amino acids (BCAAs) have beneficial effects in various liver diseases \[[@b69-jcp-24-072]\]. Peptides, molecules of a combination of amino acids linked by peptide bonds, have been studied as promising therapeutics in the treatment of cancer diseases \[[@b70-jcp-24-072],[@b71-jcp-24-072]\]. In additional studies, BCAA composed of leucine, isoleucine and valine had the inhibitory effect on the proliferation of liver cancer cells \[[@b72-jcp-24-072],[@b73-jcp-24-072]\]. However, the excessive amounts of amino acids have been reported to cause several problems. Excessive dietary intake of histidine resulted in hyperlipidemia, hepercholesterolemia and hepatic enlargement in animals \[[@b74-jcp-24-072],[@b75-jcp-24-072]\] and excessive intake of tryptophan resulted in fast weight loss in rats \[[@b76-jcp-24-072]\]. Increased circulating BCAA has been associated with non-alcoholic fatty liver disease and hepatic injury \[[@b77-jcp-24-072]\]. These results demonstrated that high protein or amino acids consumption may generate further dangerous metabolic disorders and liver injury. Therefore, the application of amino acids for the patients with liver diseases should be performed carefully. In conclusion, the treatment of amino acids in patients with liver diseases may be a promising treatment, but further studies are still needed for the proper amino acid intake and application in various liver diseases.
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![The spectrum of liver disease. A healthy liver can perform normal functions effectively. The liver can be damaged by viruses, toxins and alcohol. Fat accumulation by obesity or other factors causes fatty liver. Inflammation induced by liver injury can cause scar tissue and fibrosis. Leaving fibrosis untreated, the flow of blood through the liver is blocked and the liver function may deteriorate, which is called cirrhosis. Continuous liver disease can lead to liver cancer. HBV, hepatitis B virus; HCV, hepatitis C virus.](jcp-24-072f1){#f1-jcp-24-072}

###### 

Effects of amino acids on several liver diseases

  Amino acid       Model                                               Subsection                                               Disease                                        Treatment                    Ref No.
  ---------------- --------------------------------------------------- -------------------------------------------------------- ---------------------------------------------- ---------------------------- -----------------------
  Alanine          In vitro                                            Rat hepatocyte                                           Treated with D-gal                             60 mM                        \[[@b17-jcp-24-072]\]
  In vivo          SD rat                                              D-gal-induced hepatocyte necrosis                        Aqueous alanine solution                                                    
  Wistar rat       CCl~4~-induced hepatocyte necrosis                  2 g/kg intraperitoneal injection                                                                                                     
  C57BL/6 mouse    High-fat diet-induced obesity                       Diet                                                     \[[@b18-jcp-24-072]\]                                                       
  Glutamate        In vivo                                             Rabbit                                                   Mustard seed oil-induced oxidation             1, 2, 3 g/kg diet            \[[@b22-jcp-24-072]\]
  Piglet           LPS-induced hepatic injury                          1% AKG diet                                              \[[@b23-jcp-24-072]\]                                                       
  Aspartate        In vivo                                             Rabbit                                                   Cholesterol-fed induced fatty liver disease    12.5 mM aspartate in water   \[[@b26-jcp-24-072]\]
  Weaning piglet   LPS-induced liver injury                            0.5, 1% diet                                             \[[@b27-jcp-24-072]\]                                                       
  Glycine          In vivo                                             Wistar/Han rat                                           CCl~4~-induced hepatic fibrosis                5% diet                      \[[@b32-jcp-24-072]\]
  Lewis rat        Liver transplantation                               300 mM intravenous injection                             \[[@b33-jcp-24-072]\]                                                       
  Wistar rat       Alcohol-induced liver injury                        0.6 g/kg                                                 \[[@b34-jcp-24-072]\]                                                       
  BALB/c mouse     LPS-induced liver damage                            5% diet                                                  \[[@b36-jcp-24-072]\]                                                       
  SD rat           Intravenous injection of endotoxin                  5% diet                                                  \[[@b37-jcp-24-072]\]                                                       
  Wistar rat       Alcohol-induced liver injury                        2% diet                                                  \[[@b38-jcp-24-072]\]                                                       
  Histidine        In vivo                                             LEC rat                                                  Excess copper accumulation-induced hepatitis   Excess-histidine diet        \[[@b39-jcp-24-072]\]
  BALB/cA mouse    Acetaminophen-induced liver injury                  0.5, 1, 2 g/L in water                                   \[[@b40-jcp-24-072]\]                                                       
  BALB/cA mouse    Streptozotocin-induced diabetes                     0.5, 1 g/L in water                                      \[[@b41-jcp-24-072]\]                                                       
  C57BL/6J mouse   Histamine H~1~ receptor knockout                    Intravenous and intracerebroventricular administration   \[[@b42-jcp-24-072]\]                                                       
  C57BL/6 mouse    Hepatic steatosis-induced high saturated fat diet   1 g/L in water                                           \[[@b43-jcp-24-072]\]                                                       
  Serine           In vivo                                             C57BL/6 mouse                                            Alcohol-induced fatty liver                    20, 200 mg/kg diet           \[[@b47-jcp-24-072]\]
  Clinical         Human                                               Non-alcoholic fatty liver disease patients                                                                                           

SD, Spragur-Dawley; D-gal, D-galactosamine; LPS, lipopolysaccharide; AKG, alpha-ketoglutarate.
